What does CUSIP 64132R107 represent in this 13F holders report?

CUSIP 64132R107 is the security identifier for NRBO - NEUROBO PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held NRBO - NEUROBO PHARMACEUTICALS INC - COM in Q4 2021?

14 institutional investors reported NRBO - NEUROBO PHARMACEUTICALS INC - COM for Q4 2021. Use the holders table for investor-level position and value details.

NEUROBO PHARMACEUTICALS INC - COM (NRBO)

CUSIP: 64132R107

Q4 2021 13F Holders as of 31 Dec 2021

Security type / class: Equity / COM
Total 13F shares: 1,690,568
Total 13F value: $2,063,000
Share change: +942,017
Put/Call ratio: 66%
SEC-reported price per share: $1.22
Number of holders: 14
Value change: +$1,141,112
Number of buys: 6
Number of sells: 8

Security key

64132R107

Report period

Q4 2021

Institutions

Top holders

NRBO full security history Ownership snapshot Full 13F holder table MetaVia Inc. SEC filings MetaVia Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NRBO - NEUROBO PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

0/15

Latest evidence

03 Nov 2021

13F 3/4/5 Highest disclosed value: $1,840,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $1.84M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Disclosed position value Top 5

VANGUARD GROUP INC $1.84M

GEODE CAPITAL MANAGEMENT, LLC $226K

ELEVATION POINT WEALTH PARTNERS, LLC $214K

BlackRock Finance, Inc. $166K

CITADEL ADVISORS LLC $161K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,840,000 494,597 shares	—	30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$226,000 60,792 shares	—	30 Sep 2021
ELEVATION POINT WEALTH PARTNERS, LLC	13F Company 13F	— denominator unverified	$214,000 57,425 shares	—	30 Sep 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$166,000 44,579 shares	—	30 Sep 2021
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$161,000 43,151 shares	—	30 Sep 2021
NORTHERN TRUST CORP	13F Company 13F	— denominator unverified	$92,000 24,642 shares	—	30 Sep 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,690,568

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 value	Q4 2021 value	Value change	Value Chg %